EVNol® (Palm Tocotrienol Complex — ExcelVite)

Evidence Level
Moderate
1 Clinical Trial
3 Documented Benefits
3/5 Evidence Score

EVNol® is a full-spectrum palm tocotrienol and tocopherol complex from ExcelVite, delivering the less-common tocotrienol forms of vitamin E along with naturally co-extracted phytonutrients. Tocotrienols are potent antioxidants studied for supporting liver, heart, and brain health, with EVNol researched in fatty liver and cholesterol.

Studied Dose Commonly 200 to 400 mg of mixed tocotrienols per day.
Active Compound Full-spectrum palm vitamin E complex of alpha, beta, gamma, and delta tocotrienols plus tocopherol.

Benefits

Liver support

In a randomized placebo-controlled trial, mixed tocotrienols helped normalize the ultrasound appearance of the liver in people with non-alcoholic fatty liver, supporting liver health.

Healthy cholesterol

Tocotrienols are studied for supporting healthy total and LDL cholesterol levels.

Antioxidant protection

Tocotrienols are powerful forms of vitamin E that protect cells, including brain and blood-vessel tissue, from oxidative stress.

Mechanism of action

1

Tocotrienol antioxidant action

Tocotrienols distribute efficiently in cell membranes and quench free radicals, offering antioxidant protection beyond standard tocopherol vitamin E.

2

Cholesterol-pathway support

Tocotrienols are studied for modulating the HMG-CoA reductase pathway involved in cholesterol production.

Clinical trials

1
Tocotrienols and Fatty Liver — RCT
PubMed

Randomized placebo-controlled trial of tocotrienols for non-alcoholic fatty liver. (Magosso et al. 2013, Nutrition Journal)

Adults with non-alcoholic fatty liver.

Mixed tocotrienols helped normalize the liver's ultrasound appearance versus placebo.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated — adverse effects are uncommon at normal doses.
Mild digestive upset is occasionally reported.
Discontinue if any unusual reaction occurs.

Important Drug interactions

Anticoagulants — high-dose vitamin E forms may have a mild additive effect; monitor.
Generally compatible with other medications.
Tell your doctor before surgery if taking high doses.

Frequently asked questions about EVNol® (Palm Tocotrienol Complex — ExcelVite)

What is EVNol?

EVNol® is a full-spectrum palm tocotrienol and tocopherol complex from ExcelVite, delivering the less-common tocotrienol forms of vitamin E along with naturally co-extracted phytonutrients.

What is EVNol used for?

EVNol is researched primarily for Liver Health, Cardiovascular, and Antioxidant. In a randomized placebo-controlled trial, mixed tocotrienols helped normalize the ultrasound appearance of the liver in people with non-alcoholic fatty liver, supporting liver health.

What is the recommended dosage of EVNol?

The clinically studied dose is Commonly 200 to 400 mg of mixed tocotrienols per day. Always follow the product label and check with a healthcare provider for personal advice.

Is EVNol safe, and does it have side effects?

For most healthy adults, EVNol is well tolerated at studied doses. Reported effects can include: Generally well-tolerated — adverse effects are uncommon at normal doses. Mild digestive upset is occasionally reported. It may also interact with some medications. EVNol is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does EVNol interact with any medications?

Possible interactions include: Anticoagulants — high-dose vitamin E forms may have a mild additive effect; monitor. Generally compatible with other medications. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for EVNol?

NutraSmarts rates the evidence for EVNol as Moderate (3 out of 5). It is backed by 1 clinical trial and 1 cited reference summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(1 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Magosso E, Ansari MA, Gopalan Y, et al. Tocotrienols for normalisation of hepatic echogenic response in nonalcoholic fatty liver: a randomised placebo-controlled clinical trial. Nutr J. 2013;12(1):166..PubMedUsed to support: RCT supporting liver benefit of palm tocotrienols.